STERIS plc (STE) is a Medical - Devices company in the Healthcare sector, currently trading at $224.83. It has a SharesGrow Score of 76/100, indicating a strong investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of STE = $221.37 (-1.5% from the current price, the stock appears fairly valued). Analyst consensus target is STE = $257 (+14.2% upside).
Valuation: STE trades at a trailing Price-to-Earnings (P/E) of 30.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.95.
Financials: revenue is $5.5B, +6.2%/yr average growth. Net income is $615M, growing at +86.6%/yr. Net profit margin is 11.3% (healthy). Gross margin is 44% (+0 pp trend).
Balance sheet: total debt is $2.0B against $6.6B equity (Debt-to-Equity (D/E) ratio 0.31, conservative). Current ratio is 1.96 (strong liquidity). Debt-to-assets is 20.1%. Total assets: $10.1B.
Analyst outlook: 11 / 13 analysts rate STE as buy (85%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 41/100 (Partial), Growth 83/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 69/100 (Partial), Future 82/100 (Pass), Income 55/100 (Partial).
